This role is listed by an employer that holds a live Home Office sponsor licence on the Skilled Worker route.
Closest occupation match: SOC 2133, IT business analysts, architects and systems designers. Home Office going rate for this occupation: £54,900 a year.
Individual eligibility depends on personal circumstances. These figures are public reference information, not advice or a verdict on this job.
AVP & VP Level Opportunities (2 Roles)
Contract (33-Day Initial Assignment)
Location: London or Glasgow (Hybrid)
Start Date: Immediate
Overview
Delta Capita is seeking two experienced Business Analysts (one AVP and one VP level) to support a critical HR Transformation programme for a leading global financial services organization.
The successful candidates will join the Absence Excellence workstream, a strategic initiative focused on simplifying employee absence and workforce management processes, strengthening controls and governance, and improving colleague and manager experience through process and technology improvements.
This role requires immediate availability and will initially focus on a 33-day diagnostic and discovery phase.
Key Responsibilities
Review and refine existing problem statements and programme scope.
Conduct current-state assessments across absence and workforce management processes.
Analyse HR policies, procedures, controls, and governance frameworks.
Facilitate workshops and stakeholder interviews to gather business requirements.
Produce end-to-end process maps and journey maps.
Identify process inefficiencies, manual workarounds, and improvement opportunities.
Define business requirements and support future-state design activities.
Perform gap analysis and provide recommendations for process simplification.
Collaborate with HR, Operations, Technology, Change, and Programme stakeholders.
Support delivery of programme artefacts, documentation, and governance updates.
Ensure proposed improvements align with risk, control, and regulatory requirements.
Similar sponsored roles
All rolesLast verified against our ingestion on 18 November 2026; sponsor register dataset 2026-11-13.